Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyriphenone modification of glutaraldehyde pretreated bovine pericardium mitigates advanced glycation end products, calcification, and platelet adhesion.

Acta biomaterialia·2026
Same author

Mink by mink: stitching together signatures of subspecies adaptation through a pangenome of threatened mustelids.

Heredity·2026
Same author

The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications.

Journal of the International Society of Sports Nutrition·2026
Same author

Vitamin-B6 Pretreated Bovine Pericardial Bioprosthetic Heart Valve Leaflets Demonstrate Reduced Platelet Adhesion and Activation.

Journal of biomedical materials research. Part A·2026
Same author

Editorial: Animal models of vascular interventions.

Frontiers in cardiovascular medicine·2025
Same author

Photoacoustic imaging of vascular hyperpermeability.

IEEE International Ultrasonics Symposium : [proceedings]. IEEE International Ultrasonics Symposium·2025

Related Experiment Video

Updated: May 31, 2026

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Magnetic nanoparticles for targeted vascular delivery.

Michael Chorny1, Ilia Fishbein, Scott Forbes

  • 1Division of Cardiology Research, The Children's Hospital of Philadelphia, Philadelphia, PA. chorny@email.chop.edu

IUBMB Life
|July 2, 2011
PubMed
Summary

This study introduces a novel magnetic targeting strategy using uniform fields for deep tissue delivery. This approach aims to improve the safety and efficacy of therapies, particularly for preventing in-stent restenosis.

More Related Videos

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells
09:58

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells

Published on: May 2, 2017

Related Experiment Videos

Last Updated: May 31, 2026

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells
09:58

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells

Published on: May 2, 2017

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cardiovascular Research

Background:

  • Magnetic targeting enhances therapeutic agent delivery but faces limitations in deep tissue applications.
  • Clinical translation is hindered by challenges in carrier formulation and targeting deep tissues.

Purpose of the Study:

  • To present a novel magnetic targeting scheme using deep-penetrating uniform fields for clinical viability.
  • To demonstrate site-specific vascular delivery for preventing in-stent restenosis.

Main Methods:

  • Design of optimized magnetic carrier formulations.
  • Experimental validation of uniform field-controlled targeting for vascular delivery.
  • Application in antirestenotic therapy.

Main Results:

  • Feasibility of uniform field-controlled targeting for site-specific delivery of pharmaceuticals, biotherapeutics, and cells.
  • Demonstrated potential for preventing injury-triggered reobstruction of stented blood vessels.

Conclusions:

  • The uniform field-mediated magnetic targeting offers a clinically viable solution for deep tissue delivery.
  • This versatile approach is suitable for various therapeutic agents and holds promise for combination therapies and improved antirestenotic treatments.